Education: PhD in Hematology–Oncology from the Department of Immunology,Genetics and Pathology at Uppsala University, Sweden. Clinical Drug Development(CDD) course from Uppsala University and M.Sc. in Life Sciences from SambalpurUniversity, India.
Experience: Sujata Bhoi has extensive experience leading and managingglobal oncology clinical trials, from start-up through close-out and reporting.Backed by a strong scientific foundation in hematology and oncology, Sujata isdriven by a passion for advancing innovative therapies and contributing to thedevelopment of novel treatments for patients with unmet medical needs.
With strong expertise in clinical operations, vendorselection and management, sponsor oversight, feasibility and site selection,study start-up, trial performance monitoring, risk assessment and mitigationplanning, as well as cross-functional collaboration with internal and externalstakeholders and global study teams, Sujata brings a strategic, quality-focusedapproach to executing complex clinical studies efficiently while ensuringcompliance and operational excellence.
With extensive experience in oncology clinicaldevelopment, Sujata most recently served as Senior Clinical Trial/ ProjectManager at Medivir AB, where she managed global oncology trials across multiplecountries, served as the primary point of contact for CROs, external vendors,and global study teams, driving seamless communication and operationalalignment to ensure delivery of day-to-day trial activities on time, withinbudget, and in line with quality standards.
